Streetbeat News

Earnings

NTLA

Intellia Therapeutics (NASDAQ:NTLA) shares surged 11.2% after the company announced promising long-term data from its Phase 1 study of NTLA-2002, a CRISPR-based gene-editing therapy for hereditary angioedema (HAE). The single-dose treatment showed a 98% reduction in monthly HAE attacks and was well-tolerated with no severe side effects.

Portfolio Pulse from Dylan Berman

June 03, 2024 | 3:33 pm

SAIC

Science Applications International shares are trading lower after the company reported Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 3:29 pm

GS

Goldman Sachs Group Inc (NYSE:GS) is seen as having significant alpha generation potential despite a recent decline in stock price. Bank of America Securities' analyst Ebrahim Poonawala maintains a Buy rating and a price target of $525, citing several drivers for stock outperformance including earnings upside, capital optimization, and a shift towards higher P/E asset management revenues.

Portfolio Pulse from Priya Nigam

June 03, 2024 | 3:27 pm

ERIC

Ericsson (NASDAQ:ERIC) has announced the conclusion of its US anti-corruption compliance monitorship, which was part of a Deferred Prosecution Agreement (DPA) with the U.S. Department of Justice (DOJ). The monitorship, which began in June 2020, has been successfully completed, and the company's anti-corruption compliance program has met all requirements. Despite this positive development, Ericsson recently reported a 15% year-over-year sales decline and missed revenue expectations, although its EPS beat consensus estimates.

Portfolio Pulse from Lekha Gupta

June 03, 2024 | 3:10 pm

NBIX

Neurocrine Biosciences shares are trading higher after the company presented positive data from its CAHtalyst Phase 3 Pediatric and Adult Studies, CAHtalog Registry, and disease- and glucocorticoid-related comorbidities data in CAH at ENDO 2024.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 3:10 pm

HQY

HealthEquity, Inc. (NASDAQ:HQY) is expected to report higher Q1 earnings, with analysts projecting earnings of 66 cents per share and revenue of $278.11 million. The company recently closed the acquisition of BenefitWallet HSA portfolio. Analysts have maintained positive ratings with increased price targets.

Portfolio Pulse from Avi Kapoor

June 03, 2024 | 3:01 pm

CRWD

MSFT

NOW

ORCL

PANW

The article provides a comprehensive comparison of CrowdStrike Holdings (NASDAQ:CRWD) with its major competitors in the Software industry. Key financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth are analyzed. CrowdStrike shows high valuation ratios and strong revenue growth but lower profitability metrics compared to industry averages.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 3:00 pm

JNJ

The article provides a comprehensive comparison of Johnson & Johnson (NYSE:JNJ) with its major competitors in the Pharmaceuticals industry. Key financial metrics indicate that JNJ may be undervalued based on PE, PB, and PS ratios, but it shows underperformance in ROE, EBITDA, gross profit, and revenue growth compared to industry averages. The company's lower debt-to-equity ratio suggests a stronger financial position relative to its top peers.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 3:00 pm

ON

The article provides an in-depth analysis of ON Semiconductor (NASDAQ:ON) compared to its peers in the Semiconductors & Semiconductor Equipment industry. Key financial metrics indicate that ON Semiconductor is potentially undervalued with a low P/E, P/B, and P/S ratio. However, the company faces operational challenges with lower EBITDA, gross profit, and negative revenue growth. The debt-to-equity ratio suggests a stronger financial position compared to its top peers.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 3:00 pm

IRBO

NNDM

SCZ

Nano Dimension Ltd (NASDAQ:NNDM) reported a 10.7% year-on-year drop in Q1 revenue to $13.36 million, attributed to decreased sales. Despite this, the company improved its adjusted gross margin to 49.8% and reduced its operating loss to $18.97 million. The company also held $793.08 million in cash and equivalents as of March-end. Cost-cutting measures, including a 25% workforce reduction, are expected to save $30 million annually. NNDM shares are down 3.497% to $2.625.

Portfolio Pulse from Anusuya Lahiri

June 03, 2024 | 2:30 pm